Page last updated: 2024-10-29

iomeprol and Seizures

iomeprol has been researched along with Seizures in 3 studies

iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.

Research Excerpts

ExcerptRelevanceReference
"To compare the incidence of seizures in dogs with intervertebral disk disease after iopamidol or iomeprol myelography, and to assess whether the incidence of seizures differed between the 2 agents when severity of neurological deficits, location of cord compression, duration of anesthesia, site of myelogram, volume of contrast, and concentration of contrast were evaluated."7.75Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002). ( Dvorak, M; Kecova, H; Lexmaulova, L; Necas, A; Proks, P; Rauser, P; Srnec, R; Zatloukal, J, 2009)
"To compare the incidence of seizures in dogs with intervertebral disk disease after iopamidol or iomeprol myelography, and to assess whether the incidence of seizures differed between the 2 agents when severity of neurological deficits, location of cord compression, duration of anesthesia, site of myelogram, volume of contrast, and concentration of contrast were evaluated."3.75Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002). ( Dvorak, M; Kecova, H; Lexmaulova, L; Necas, A; Proks, P; Rauser, P; Srnec, R; Zatloukal, J, 2009)
"Repeated seizures and prolonged motor weakness developed in a 26-year-old woman after cerebral angiography."1.36Contrast medium-induced seizures and prolonged motor weakness after cerebral angiography: case report. ( Ishii, A; Kawamata, T; Mitsuyama, T; Sato, S, 2010)
"Iomeprol was well tolerated in both rats and dogs following weekly intrathecal administrations for four weeks of doses up to three times higher than those foreseen for clinical use."1.29Preclinical safety assessment of iomeprol for injection as contrast medium for myelography. ( Bertani, F; de Haën, C; La Noce, A; Lorusso, V; Luzzani, F; Tirone, P, 1994)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lexmaulova, L1
Zatloukal, J1
Proks, P1
Dvorak, M1
Srnec, R1
Rauser, P1
Kecova, H1
Necas, A1
Mitsuyama, T1
Sato, S1
Ishii, A1
Kawamata, T1
La Noce, A1
Bertani, F1
Lorusso, V1
Luzzani, F1
Tirone, P1
de Haën, C1

Other Studies

3 other studies available for iomeprol and Seizures

ArticleYear
Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002).
    Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001), 2009, Volume: 19, Issue:6

    Topics: Animals; Cervical Vertebrae; Contrast Media; Dog Diseases; Dogs; Female; Intervertebral Disc Displac

2009
Contrast medium-induced seizures and prolonged motor weakness after cerebral angiography: case report.
    Neurosurgery, 2010, Volume: 67, Issue:5

    Topics: Adult; Cerebral Angiography; Contrast Media; Diagnosis, Differential; Female; Humans; Iopamidol; Mus

2010
Preclinical safety assessment of iomeprol for injection as contrast medium for myelography.
    European journal of radiology, 1994, Volume: 18 Suppl 1

    Topics: Animals; Anticonvulsants; Blood; Contrast Media; Dogs; Drinking; Drug Interactions; Electroencephalo

1994